A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
The conversation surrounding healthcare reform has intensified in recent years, revealing deep divides in how we view ...
The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
An international commission made the case for focusing on body fat quantity and the illnesses people experience.
On the latest episode of her podcast, Oprah Winfrey opened up about how her opinion of “thin people” changed after she was able to lose weight herself with the help of weight loss medications.
Obesity medications promise transformative care, but financial and systemic barriers limit access for those most in need.
News Medical on MSN2d
Why do people with obesity, but without diabetes, start taking semaglutide?Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...
The effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, ...
A coalition of obesity-related patient advocacy groups is calling on the incoming Trump administration to finalize a proposal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback